Nov 30, 2022 / 05:00PM GMT
David A. Amsellem - Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Okay. Good afternoon, everyone. David Amsellem from the Piper Sandler Specialty Pharma team. Welcome again to the 34th Annual Piper Sandler Healthcare Conference. We're delighted to have Jazz Pharmaceuticals join us. So we have senior management with us, Renee Gala, CEO -- sorry CFO; Robbie Iannone, Global Head of R&D; Abizer Gaslightwala from the Oncology business unit; P.J. Honerkamp from the Sleep Medicine business unit. Other than promoting you to CEO, I hope I didn't butcher the introductions. Well, anyway, thanks for joining us.
I'll turn it over to you, Renee, for just some brief introductory remarks, and then we can go right into Q&A, if that's okay.
Renee D. Gala - Jazz Pharmaceuticals plc - Executive VP & CFO
Yes. That sounds great. And thank you again for the promotion. That's wonderful. Just a few reminders. One, we'll be making forward-looking statements today. These are all subject to risk factors, and you can learn more about
Jazz Pharmaceuticals PLC at Piper Sandler Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers